TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
LEO Pharma A/S
Closing information (x1000 DKK)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover | 10,133,000 | 10,805,000 | 10,410,000 |
Earnings before taxes | -1,080,000 | -1,705,000 | 1,416,000 |
Total assets | 23,853,000 | 24,760,000 | 16,284,000 |
Current assets | 8,610,000 | 9,421,000 | 6,963,000 |
Current liabilities | 6,098,000 | 5,587,000 | 4,739,000 |
Equity capital | 6,947,000 | 8,088,000 | 9,528,000 |
- share capital | 250,000 | 250,000 | 250,000 |
Employees (average) | 1,000 | 1,000 | 1,000 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency | 29.1% | 32.7% | 58.5% |
Turnover per employee | 10,133 | 10,805 | 10,410 |
Profit as a percentage of turnover | -10.7% | -15.8% | 13.6% |
Return on assets (ROA) | |||
Current ratio | 141.2% | 168.6% | 146.9% |
Return on equity (ROE) | -15.5% | -21.1% | 14.9% |
Change turnover | -672,000 | 395,000 | -71,000 |
Change turnover % | -6% | 4% | -1% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.